Guaranteed EUA - most likely leading to full approval with additional open label data of critical patients. Likely multi country sales in the billions. The only thing better than these results are outcome is primary endpoint with because it had dis-proportionate severe patients vs critical so a couple deaths literally stopped from hitting pvalue as well as not having more criticals. Janet Woodcock has already stated Pvalues will be of less focus vs actual results. Stock price should really gap up. As media and I mean big media starts running stories on leronlimab it will bring in tons new investors. Most investors know what they have CEO says 3 digit stock ans I can see it has that potential others might wait to sell until $25 -$30 but a very small minority are going to be selling under that amount. We have long haulers started up today ans that will start getting more national media. Only ones selling might be shorts if they are truly brain dead I hope some more PR’s hit by Monday morning to help drive price up. Leronlimab is clearly doing what many of us though it’s saving lives many lives and it’s also super safe little to no side effects. Huge benefit no risk and no other drug remotely close. I feel it woulda been grand-slam instead of a home run had been closer to 30% mortality reduction day 28 yet we don’t even have the day 42 or day 60? Maybe those numbers will be a grand-slam. I think we grand-slammed the secondary endpoints. Very exciting week ahead. Can’t wait for the conference call. I’m already all in but will be buying more since my thoughts about the trail have been now confirmed. GLtA longs